Or. Admin. Code § 836-200-0545 - Public Disclosure of Prescription Drug Manufacturer Filings

(1) As soon as practicable after receiving a filing from a prescription drug manufacturer under OAR 836-200-0530 to 836-200-0532, the department shall post to its website the name of the manufacturer and the prescription drug that is the subject of the filing.
(2) Notwithstanding section (1), if a manufacturer has made a trade secret claim, the information that is the subject of the trade secret claim will not be posted to the department's website until a determination has been made by the department or, in the case of a manufacturer's appeal, the director, as specified by OAR 836-200-0540.
(3) No information determined by the department or the director to be exempt from disclosure under OAR 836-200-0540 shall be included in the information posted to the department's website.

Notes

Or. Admin. Code § 836-200-0545
ID 2-2019, adopt filed 02/26/2019, effective 3/1/2019; ID 1-2020, amend filed 01/29/2020, effective 2/1/2020; ID 2-2025, amend filed 03/26/2025, effective 4/1/2025

Statutory/Other Authority: ORS 646A.689

Statutes/Other Implemented: ORS 646A.689

State regulations are updated quarterly; we currently have two versions available. Below is a comparison between our most recent version and the prior quarterly release. More comparison features will be added as we have more versions to compare.